|
|
Reference
|
|
   3
|
Agarwal, R. (2005) Hypertension and survival in chronic hemodialysis patients: Past lessons and future opportunities. Kidney Int, 67(1): 1-13
|
|
|
Amann, K., Ritz, E. (2001) The heart in renal failure: Morphological changes of the myocardium-new insights. J Clin Basic Cardiol, 4, 109-13
|
|
|
Amann, K., Tyralla, K. (2002) Cardiovascular changes in chronic renal failure: Pathogenesis and therapy. Clin Nephrol, 58 Suppl 1: S62-72
|
|
1
|
Beciani, M., Tedesco, A., Violante, A., Cipriani, S., Azzarito, M., Sturniolo, A., Splendiani, G. (2003) Cardiac troponin I (2nd generation assay) in chronic haemodialysis patients: Prevalence and prognostic value. Nephrol Dial Transplant, 18(5): 942-6
|
|
1
|
Berl, T., Henrich, W. (2005) Kidney-heart interactions: Epidemiology, pathogenesis, and treatment. Clinical Journal of the American Society of Nephrology, 1(1): 8
|
|
1
|
Block, G.A., Spiegel, D.M., Ehrlich, J., Mehta, R., Lindbergh, J., Dreisbach, A. (2005) Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney International, 68(4): 1815
|
|
2
|
Block, G., Port, F.K. (2003) Calcium phosphate metabolism and cardiovascular disease in patients with chronic kidney disease. Semin Dial, 16(2): 140-7
|
|
|
Bocksch, W., Fateh-Moghadam, S., Mueller, E., Huehns, S., Waigand, J., Dietz, R. (2005) Percutaneous coronary intervention in patients with end-stage renal disease. Kidney Blood Press Res, 28(5-6), str. 270-4
|
|
3
|
Buccianti, G., Raselli, S., Baragetti, I., Bamonti, F., Corghi, E., Novembrino, C., Patrosso, C., Maggi, F.M., Catapano, A.L. (2002) 5-methyltetrahydrofolate restores endothelial function in uraemic patients on convective haemodialysis. Nephrol Dial Transplant, 17(5): 857-64
|
|
1
|
Chertow, G.M., Burke, S.K., Raggi, P., treat To Goal Working Group (2002) Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int, 62(1): 245-52
|
|
|
Dennis, V.W. (2005) Coronary Heart Disease in Patients with Chronic Kidney Disease. Journal of the American Society of Nephrology, 16(11_suppl_2): S103
|
|
|
Foley, R. (2002) Cardiac disease in diabetic patients with renal disease. Acta Diabetol, 39 Suppl 1: S9-14
|
|
2
|
Furgeson, S.B., Chonchol, M. (2008) Beta-blockade in chronic dialysis patients. Seminars in Dialysis, 21(1): 43
|
|
3
|
Goldsmith, D.J., Covic, A. (2001) Coronary artery disease in uremia: Etiology, diagnosis, and therapy. Kidney Int, 60(6): 2059-78
|
|
|
Gross, M.L., Ritz, E. (2008) Hypertrophy and fibrosis in the cardiomyopathy of uremia-beyond coronary heart disease. Seminars in Dialysis, 21(4): 308
|
|
|
Gupta, R., Birnbaum, Y., Uretsky, B.F. (2004) The renal patient with coronary artery disease: current concepts and dilemmas. J Am Coll Cardiol, 44(7): 1343-53
|
|
2
|
Herzog, C.A., Mangrum, J.M., Passman, R. (2008) Sudden Cardiac Death and Dialysis Patients. Seminars in Dialysis, 21(4): 300
|
|
|
Herzog, C.A., Littrell, K., Arko, C., Frederick, P.D., Blaney, M. (2007) Clinical characteristics of dialysis patients with acute myocardial infarction in the United States: a collaborative project of the United States Renal Data System and the National Registry of Myocardial Infarction. Circulation, 116(13): 1465
|
|
3
|
Herzog, C.A. (2007) Can we prevent sudden cardiac death in dialysis patients?. Clinical Journal of the American Society of Nephrology, 2(3): 410
|
|
2
|
Herzog, C.A. (2003) How to manage the renal patient with coronary heart disease: the agony and the ecstasy of opinion-based medicine. J Am Soc Nephrol, 14(10): 2556-72
|
|
4
|
Herzog, C.A. (2003) Cardiac arrest in dialysis patients: Approaches to alter an abysmal outcome. Kidney Int Suppl, (84): S197-200
|
|
1
|
Hussein, M., Mooij, J., Roujouleh, H., i dr. (2004) Cardiac troponin-I and its prognostic significance in a dialysis population. Hemodialysis International, 8(4): 332
|
|
4
|
Johnson, D.W., Craven, A.M., Isbel, N.M. (2007) Modification of cardiovascular risk in hemodialysis patients: An evidence-based. Hemodial Int, 11(1), str. 1-14
|
|
3
|
Johnston, N., Dargie, H., Jardine, A. (2008) Diagnosis and treatment of coronary artery disease in patients with chronic kidney disease. Heart, 94(8): 1080
|
|
1
|
Kemp, M., Donovan, J., Higham, H., Hooper, J. (2004) Biochemical markers of myocardial injury. Br J Anaesth, 93(1): 63-73
|
|
2
|
Lacson, E., Levin, N.W. (2004) C-reactive protein and end-stage renal disease. Semin Dial, 17(6): 438-48
|
|
|
Levey, A.S., Eknoyan, G. (1999) Cardiovascular disease in chronic renal disease. Nephrol Dial Transplant, 14(4): 828-33
|
|
|
Liu, Y., Coresh, J., Eustace, J.A., Longenecker, C.J., Jaar, B., Fink, N.E., Tracy, R.P., Powe, N.R., Klag, M.J. (2004) Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA, 291(4): 451-9
|
|
4
|
Locatelli, F., Bommer, J., London, G.M., Martín, A., Wanner, C., Yaqoob, M., Zoccali, C. (2001) Cardiovascular disease determinants in chronic renal failure: clinical approach and treatment. Nephrol Dial Transplant, 16(3): 459-68
|
|
|
Locatelli, F., Covic, A., Chazot, C., Leunissen, K., Luño, J., Yaqoob, M., accorde Programme (2004) Hypertension and cardiovascular risk assessment in dialysis patients. Nephrol Dial Transplant, 19(5): 1058-68
|
|
10
|
London, G.M. (2003) Cardiovascular disease in chronic renal failure: Pathophysiologic aspects. Semin Dial, 16(2): 85-94
|
|
3
|
Mallamaci, F., Zoccali, C., Tripepi, G., Fermo, I., Benedetto, F.A., Cataliotti, A., Bellanuova, I., Malatino, L.S., Soldarini, A., Creed Investigators (2002) Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int, 61(2): 609-14
|
|
|
Marwick, T.H. (2006) Diabetic heart disease. Heart, 92(3): 296- 300
|
|
1
|
Massy, Z.A., Kasiske, B.L. (2000) Prevention of cardiovascular complications in chronic renal disease. New York: Oxford University Press, str. 463-81
|
|
1
|
Massy, Z.A. (2003) Potential strategies to normalize the levels of homocysteine in chronic renal failure patients. Kidney Int Suppl, (84): S134-6
|
|
3
|
Mccullough, P.A. (2007) Coronary artery disease. Clinical Journal of the American Society of Nephrology, 2(3): 611
|
|
1
|
Mccullough, P.A. (2005) Evaluation and treatment of coronary artery disease in patients with end-stage renal disease. Kidney Int Suppl, (95): S51-8
|
|
10
|
Middleton, R.J., Parfrey, P.S., Foley, R.N. (2001) Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol, 12(5): 1079-84
|
|
2
|
Murphy, S.W. (2003) Management of heart failure and coronary artery disease in patients with chronic kidney disease. Semin Dial, 16(2): 165-72
|
|
5
|
Nolan, C.R. (2005) Strategies for improving long-term survival in patients with ESRD. J Am Soc Nephrol, 16(Suppl 2), str. 120-7
|
|
8
|
Panteghini, M. (2004) Role and importance of biochemical markers in clinical cardiology. Eur Heart J, 25(14): 1187-96
|
|
5
|
Panteghini, M. (2004) Biohemijski markeri srčanih oboljenja. Jugoslovenska medicinska biohemija, vol. 23, br. 3, str. 201-211
|
|
13
|
Parfrey, P.S. (2000) Cardiac disease in dialysis patients: Diagnosis, burden of disease, prognosis, risk factors and management. Nephrol Dial Transplant, 15 Suppl 5: 58-68
|
|
5
|
Parfrey, P.S., Foley, R.N. (1999) The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol, 10(7): 1606-15
|
|
1
|
Petrovic, D., Obrenovic, R., Stojimirovic, B.B. (2008) Cardiac troponins and left ventricular hypertrophy in hemodialysis patients
|
|
1
|
Petrović, D., Stojmirović, B. (2009) Secondary hyperparathyroidism: A risk facror for the development of cardiovascular complications in hemodialysis patients. Medicinski pregled, 62: In press
|
|
|
Petrović, D., Stojimirović, B. (2006) Managing dyslipidemia in dialysis patients. Niš: Medical faculty, str. 69-79. (Serbian)
|
|
|
Petrović, D., Stojimirović, B. (2005) Homocystein: A risk factor for the development of cardiovascular complications in hemodialysis patient. Niš: GIP 'PUNTA', 2, p. 31-6
|
|
|
Petrović, D., Stojimirović, B. (2007) Prevalence of risk factors for development of cardiovascular complications in hemodialysis patients. Naiss: GIP 'PUNTA', 35-43
|
|
|
Petrović, D., Stojimirović, B. (2007) Left ventricle hypertrophy - risk factor for the development of ischemic heart disease. Kragujevac: Inter Print, p. 46-58
|
|
4
|
Petrović, D., Stojimirović, B. (2008) Hipertrofija leve komore kod bolesnika koji se leče redovnim hemodijalizama. Medicinski pregled, vol. 61, br. 7-8, str. 369-374
|
|
6
|
Petrović, D., Stojimirović, B. (2007) Protok krvi kroz vaskularni pristup za hemodijalizu - faktor rizika za razvoj kardiovaskularnih komplikacija kod bolesnika na hemodijalizi. Medicinski pregled, vol. 60, br. 3-4, str. 183-186
|
|
|
Petrović, D., Obrenović, R., Poskurica, M., Stojimirović, B. (2007) Correlation of C-reactive protein with echocardiographic parameters of hypertrophic and ischemic heart disease in patients on regular hemodialyses. Medicinski pregled, 60 Suppl 2: 160-4
|
|
5
|
Petrović, D., Jagić, N., Miloradović, V., Stojimirović, B. (2008) Klinički značaj biohemijskih markera srčanog oštećenja kod pacijenata na hemodijalizi. Serbian Journal of Experimental and Clinical Research, vol. 9, br. 1, str. 19-25
|
|
6
|
Petrović, D., Stojimirović, B. (2008) Kardiovaskularni morbiditet i mortalitet bolesnika na hemodijalizi - epdiemiološka analiza. Vojnosanitetski pregled, vol. 65, br. 12, str. 893-900
|
|
|
Remppis, A., Ritz, E. (2008) Cardiac Problems in the Dialysis Patient: Beyond Coronary Disease. Seminars in Dialysis, 21(4): 319
|
|
11
|
Rigatto, C., Parfrey, P.S. (2001) Uraemic cardiomyopathy: An overload cardiomyopathy. J Clin Basic Cardiol, 4, str. 93-5
|
|
4
|
Sood, M.M., Pauly, R.P., Rigatto, C., Komenda, P. (2008) Left ventricular dysfunction in the haemodialysis population. NDT Plus, 1(4): 199
|
|
1
|
Stojimirović, B., Petrović, D., Obrenović, R. (2007) Left ventricle hypertrophy in hemodialysis patients: significance of anemia. Med Pregl, 60(Suppl 2): 155-9
|
|
|
Tyralla, K., Amann, K. (2002) Cardiovascular changes in renal failure. Blood Purif, 20(5): 462-5
|
|
2
|
Ward, R.A. (2004) Ultrapure dialysate. Semin Dial, 17(6): 489-97
|
|
|
Wheeler, D.C., Baigent, C. (2000) Cardiovascular risk factors in chronic renal failure. New York: The Oxford University Press, p. 3-28
|
|
|
Williams, M.E. (2006) Coronary revascularization in diabetic chronic kidney disease/end-stage renal disease: A nephrologist's perspective. Clinical Journal of the American Society of Nephrology, 1(2): 209
|
|
10
|
Zoccali, C., Mallamaci, F., Tripepi, G. (2004) Novel cardiovascular risk factors in end-stage renal disease. J Am Soc Nephrol, 15 Suppl 1: S77-80
|
|
|
|
|